Emergent Biosolutions

This study tested a new anthrax vaccine called AV7909 in nearly 3,700 healthy adults to see if it works as well as the current licensed vaccine (BioThrax) for preventing anthrax after exposure. Participants received either AV7909 or BioThrax, and researchers measured their immune…

This study looked at whether giving an anthrax vaccine (AV7909) along with antibiotics (ciprofloxacin or doxycycline) changes how the body handles the drugs or the vaccine. It involved 210 healthy adults aged 18 to 45. The goal was to ensure the vaccine and antibiotics can be use…

This study tested a new device (AP003) that delivers naloxone as a nasal spray to reverse opioid overdoses. Twenty-four healthy adults received multiple doses to see how the drug moves through the body and to check for side effects. The goal was to compare the new spray with the …